Formycon Begins Biosimilar Ustekinumab Trial

Phase I Trial Announcement Comes Shortly After NeuClone

 
• By David Wallace
  
Race_Track
Formycon’s Phase I trial has got off the blocks at around the same time as NeuClone’s • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products